U.S. pharma huge copyright scrapped two experimental weight loss supplements final 12 months—a when-every day pill, lotiglipron, because of elevated liver enzymes and also a 2 times-daily pill, danuglipron, due to robust Unwanted side effects—but CEO Albert Bourla has stated the company is determined to “Participate in and earn” from the ob